GSK plc

GSKleader

GSK is a global biopharma company focused on infectious diseases, HIV, respiratory, and immunology, with the world's leading shingles vaccine Shingrix and majority-owned ViiV Healthcare.

⇄ Compare

Products & Revenue

Product Revenue Share

Revenue Breakdown ($37.5B)

Static data (loading live financials…)

Commercial (Specialty) (50%)

Vaccines (28%)

General Medicines (22%)

Segment Breakdown & Key Customers

Product Details

HIV (ViiV Healthcare)28%

Dolutegravir-based regimens — world's most prescribed HIV treatments

Shingrix & Vaccines25%

#1 shingles vaccine and broad vaccine portfolio

Respiratory22%

Trelegy Ellipta and Nucala for asthma/COPD

Oncology & Other25%

Zejula (PARP inhibitor) and general medicines

Supply Chain Relationships

Competitors

Pfizer Inc.

Vaccines and respiratory

Impact: High — overlapping vaccine portfolios

Sanofi

Vaccines

Impact: Medium — vaccine market competition

Merck & Co.

Vaccines (Gardasil vs Shingrix market)

Impact: Medium — different vaccine segments

Macro & Market Context

제약 / 바이오Sector News

GLP-1 메가트렌드 + AI 신약개발 + 저평가 바이오 기관 매집

GLP-1 시장 규모 (2030E)

$150B

mRNA 암백신 임상 성공률

+49% 재발 위험 감소

AI 신약개발 단계

임상 2상 진입

PFE/MRNA 52주 변화

-30% ~ -45%

Upcoming Catalysts

◆LLY Orforglipron(경구용 GLP-1) 3상 결과 (2026.Q2)◆MRNA 암백신 FDA BLA 제출 예정◆REGN EYLEA HD 유럽 허가 결과

Latest News

Loading news...

AI Analysis

Click "Get AI Analysis" for an AI-powered supply chain analysis of GSK plc.

Company Info

Headquarters

London, United Kingdom

Founded

2000

Employees

70,000+

Website

gsk.com

Sector Overview — 제약 / 바이오

Sector News